Belhabri, Amine <br/><br/>
All trans retinoic acid in combination with intermediate-dose cytarabine and idarubicin in patients with relapsed or refractory non promyelocytic acute myeloid leukemia: a phase II randomized trial.  [electronic resource] 

 -  The hematology journal : the official journal of the European Haematology Association  2002 
 - 49-55 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Comparative Study; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1466-4860 
<br/><br/><label>Standard No.: </label>10.1038/sj.thj.6200141  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Cytarabine--administration & dosage<br/>Female<br/>Humans<br/>Idarubicin--administration & dosage<br/>Leukemia, Myeloid--complications<br/>Male<br/>Middle Aged<br/>Remission Induction<br/>Salvage Therapy<br/>Survival Analysis<br/>Therapeutic Equivalency<br/>Treatment Outcome<br/>Tretinoin--administration & dosage